SCHEMBL7202525

SCHEMBL7202525

C#CCCC#COC(=O)CCCOCC

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7203348 0.95 TSHR (0.33) TSHR
SCHEMBL28429680 0.84 L3MBTL1 (0.36) SMN1; SMN2ALDH1A1
SCHEMBL11538431 0.84 CYP1A2 (0.36) TSHR
SCHEMBL1482994 0.84 CYP1A2 (0.41)
SCHEMBL11537702 0.82 CYP1A2 (0.44) ALDH1A1
SCHEMBL11538423 0.82 CYP1A2 (0.44) ALDH1A1
SCHEMBL11538435 0.82 CYP1A2 (0.44) ALDH1A1
SCHEMBL4446047 0.80 CYP1A2 (0.34)
SCHEMBL28230165 0.78 CYP1A2 (0.53) TSHRALDH1A1
SCHEMBL28387307 0.74 CYP1A2 (0.42) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6607868-B2 Dipropargyl acetamide HYNIX SEMICONDUCTOR INC. (KR) 2003-08-19 US disclosed
US-20020012879-A1 Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same HYNIX SEMICONDUCTOR INC. (KR) 2002-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020012879-A1 Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same CDH1, DDAH1, DPEP1 TSHR 4702/4885SMN1; SMN2 2358/4885ALDH1A1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.